Jumat, 03 April 2026

Elon's Master Plan Is Unfolding Right Before Your Eyes

BONUS: The GLP-1 Buyout Wave Is Just Getting Started  ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌

A message from our friends at Brownstone Research (sponsor)

Elon's Master Plan Is Unfolding Right Before Your Eyes

Editor's Note: Silicon Valley legend Jeff Brown is forecasting that Elon Musk's "Kardashev Project" is about to trigger the greatest wealth creation event in history. If you missed out on Tesla... Click here to see the details of what Elon has coming next or read more below.

 

Dear Reader,

Elon Musk has transformed more American industries than maybe anyone in the world.

Today, well positioned investors have a chance to profit as it all comes together.

He gave manufacturing its biggest overhaul since Henry Ford.

In fact, the term "Factory-is-the-Product" was created to describe Tesla's radical business model. Centered around Gigafactories pushing cars out with 95% automation in under forty seconds.

With SpaceX, he's dropped the cost to launch material into space by 97%. Becoming the backbone of the U.S. space program.

And then there's AI.

Most people forget, Musk founded the company behind ChatGPT. Recently, his own AI, Grok, beat out ChatGPT to become the world's top public AI.

These may seem like separate businesses, and they largely have been...

Until now.

Elon Musk is bringing all of his most revolutionary technologies together in Phase II of his master plan. A plan he believes will unleash a quadrillion-dollar wealth creation event.

But as usual, the media is focusing on bringing Musk down instead of talking about the real story.

The story investors should care about.

Legendary Silicon Valley insider and tech investor Jeff Brown is sharing the full story - including where you should put your money before April 30th - in this brief video.

There's still time to get in, but you have to move fast.

Jeff believes Elon could be making a new announcement by the end of this month that the mainstream media won't be able to ignore.

By the time this story is plastered across the pages of The New York Times and The Wall Street Journal the best opportunity will be past.

Click here now to watch Jeff Brown's latest tech briefing where he reveals the full story you won't hear anywhere else.

Regards,

Lindsey Hough
Managing Director, Brownstone Research

BONUS ARTICLE

The GLP-1 Buyout Wave Is Just Getting Started

Hey there, bargain hunter…

This isn't just another biotech headline.

It's the start of a land grab.

Eli Lilly's reported $7.8 billion acquisition of Centessa (CNTA) just fired the starting gun on what looks like a full-blown GLP-1 M&A cycle.

And when big pharma starts writing checks like that…

It's usually not the last one.

 

Scoreboard: What Actually Happened

Let's simplify the setup:

  • Eli Lilly acquires Centessa for ~$7.8B

  • GLP-1 weight-loss drugs are now a $100B+ long-term market opportunity

  • Big pharma has:

    • Massive cash piles

    • Aging pipelines

    • Urgent need for next-gen obesity treatments

Translation:

They're not buying because they want to.

They're buying because they have to.

 

The Real Reason This Is Happening

This is a classic scarcity trade.

Right now, the GLP-1 landscape is dominated by two giants:

  • Eli Lilly

  • Novo Nordisk

Everyone else?

Playing catch-up.

And here's the problem:

You can't build a competitive obesity drug pipeline overnight.

Clinical timelines are long.
Regulatory hurdles are real.
Success rates are low.

So what do you do if you're big pharma?

You buy it.

 

Deep Dive: The "Scarcity Value" Setup

This is where things get interesting for a Cheap Investor lens.

Because this isn't about dozens of targets.

It's about a limited pool of viable assets.

The key traits buyers are hunting:

  • Oral GLP-1 candidates (next-gen convenience)

  • Better tolerability profiles

  • Strong early-stage efficacy data

  • Scalable manufacturing potential

That list is short.

And when supply is limited—but demand is massive—

Prices move fast.

 

The Rising Star: Viking Therapeutics (VKTX)

If you're looking for the next domino, traders are already circling one name:

Viking Therapeutics (VKTX)

Why?

  • Strong data in obesity trials

  • Positioned in the GLP-1 / metabolic space

  • Still mid-cap relative to Lilly/Novo scale

This is exactly the kind of profile that gets attention in a cycle like this.

Not guaranteed.

But very much in play.

 

Is It Cheap?

Here's where discipline matters.

Biotech M&A cycles can create two types of "cheap":

1) Pre-takeout mispricing

Stocks that are undervalued relative to their pipeline potential

2) Post-hype momentum

Stocks that get bid up purely on speculation

Right now, VKTX is walking that line.

The bullish argument:

  • Scarcity + strong data = potential premium buyout

The cautious take:

  • A lot of that narrative may already be getting priced in

 

Bull / Base / Bear

Bull Case

  • More deals follow Lilly's move

  • VKTX or similar names get acquired at a premium

  • GLP-1 market expands faster than expected

→ Biotech multiples re-rate higher

 

Base Case

  • Selective M&A continues

  • Only the strongest pipelines get bought

  • Stocks trade on data + speculation

→ Volatility, but opportunity remains

 

Bear Case

  • M&A slows after initial deals

  • Clinical data disappoints

  • Valuations outrun fundamentals

→ "Takeout premium" fades quickly

 

Action Plan for the Cheap Investor

This is not a spray-and-pray biotech trade.

You want to be selective.

Focus on:

  1. Clinical data quality

  2. Pipeline differentiation

  3. Positioning within GLP-1 ecosystem

Avoid:

  • Pure speculation without data

  • Chasing spikes on takeover rumors

 

Cheap Investor Checklist

Track these signals:

  1. Additional GLP-1 acquisitions

  2. Viking Therapeutics trial updates

  3. Oral GLP-1 developments

  4. Big pharma pipeline gaps

  5. Regulatory milestones

  6. Sector-wide valuation shifts

 

Bottom Line

This is not just a biotech rally.

It's a scarcity-driven acquisition cycle.

Big pharma needs growth.
GLP-1 is the prize.
And there aren't many credible players left to buy.

That's why deals are happening.

And that's why names like Viking Therapeutics are getting attention.

Just remember:

In M&A-driven markets, the upside can be fast—

But so can the disappointment.

Stay selective. Stay disciplined.

 

Disclaimer: This article is for informational purposes only and does not constitute investment advice. Investing involves risk, including the potential loss of principal. Always do your own research before making investment decisions.

IMPORTANT NOTICE AND DISCLAIMER
Investing Media Solutions, LLC ("IMS"), the owner of this website (the "Website"), cannot guarantee the accuracy or completeness of the information contained in any article, email, newsletter, or other publication posted on or viewed in connection with this website (the "Publications"). The author or authors of those Publications are solely responsible for their contents. IMS has not done any research or due diligence into the markets, industries, or companies which may appear or be mentioned in the Publications. IMS will NOT be liable for any loss or damage caused by a reader's reliance on information posted on the Website or contained in the Publications.

FOR EDUCATIONAL AND INFORMATIONAL PURPOSES ONLY; NOT INVESTMENT ADVICE.
This Website and the Publications are for educational and informational purposes only. This Website and the Publications do not purport to be a complete analysis of any company's financial position. This Website, the Publications or any statements made in the Publications are not, and should not be construed to be, personalized investment advice directed to or appropriate for any particular individual. This Website or the statements made in the Publications should NOT be relied upon for purposes of transacting in any securities posted on the Website or mentioned in the Publications, nor should they be construed as a personalized recommendation to you to buy, sell, or hold any position in any security posted on this Website or mentioned in any Publications.

SUBSTANTIAL RISK IN INVESTMENT.
Any individual who chooses to invest in any securities including those mentioned in the Publications should do so with caution. Investing or transacting in securities involves substantial risk; you may lose some, all, or possibly more than your original investment. Readers bear responsibility for their own investment research and decisions and should review all investment decisions with a licensed or registered investment professional.

NOT AN INVESTMENT ADVISOR OR REGISTERED BROKER
Neither IMS nor any of its respective owners or employees are registered or licensed as a securities broker-dealer, broker, an investment advisor, or an investment advisor representative with the U.S. Securities and Exchange Commission (SEC), any state securities regulatory authority, or any self-regulatory organization.

To more fully understand our Website, please review our full disclaimer located at: https://thecheapinvestor.com/disclaimer/

At The Cheap Investor, it's our mission to create and provide a community that helps you invest and understand stocks. When TheCheapInvestor was established, we wanted to make the community an inclusive place where investors can come to get ahead! Not just help them with daily stock picks. The Cheap Investor are provided to you for information only and should not be considered as a stock or investment advisor. The Cheap Investor may make available certain information related to trading strategies and stock prices for educational and information purposes only; any information made available should not be construed as an endorsement, recommendation, or sponsorship of any company or security. By visiting this site or using the training materials, you acknowledge and agree that any reliance upon the content or data available through The Cheap Investor is at your own sole risk. You are strongly advised to use your own judgment, research, and consult a professional advisor.

Over the years, and with thousands of followers that use our stock picks daily, we promise to always aim to get better at what we do every single day! In addition, our primary focus is on our communication with you. It's really important to us that every time you come to us, you end up leaving with the help you came for to take your investment portfolio to new levels.

We particularly appreciate when our following provides feedback via testimonials, reviews, and comments left on our site or social media accounts. Because with that feedback, we can use it to make your next visit to our site even better than the last!

Since we put so much effort into the relationship with you, we hope that any investment in us is exactly the way you hoped it would be. Because by choosing to go with https://TheCheapInvestor.com/, it's our promise that we provide a community you will come back to over and over again.

Now, as much as we care about making investors more successful, we also care about your privacy. TheCheapInvestor is owned and operated by TheCheapInvestor website.

We're committed to the right to your privacy and strive to provide a safe and secure user experience. Our Privacy Policy explains how we collect, store and use personal information, provided by you on our website.

What Information Do We Collect?

When you visit our Web site you may provide us with two types of information: personal information you knowingly choose to disclose that is collected on an individual basis and Web site use information collected on an aggregate basis as you and others browse our Web site.

For example, you may need to provide the following information: • Name • Website URL information • Email address • Home and business phone number

In addition to providing the foregoing information, if you choose to correspond further with us through email, we may retain the content of your email messages together with your email address and our responses. We provide the same protections for these electronic communications that we employ in the maintenance of information received by mail and telephone. It also explains important information that ensures we won't abuse the information that you provide to us in good faith. By accessing and using our website, you can trust that what you want to be kept private, will be kept private. If at any time, you would like to read our Privacy Policy and get a better understanding of your rights and liabilities under the law.

Feel free to visit our site, find the privacy policy in the footer and read it. If there is something you are concerned about or wish to get more clarity on, please let us know by contacting us at support@thecheapinvestor.com. The Privacy Policy also informs you of how to notify us to stop using your personal information. If you wish to view our official policies, please visit our website https://TheCheapInvestor.com/

At The Cheap Investor, we are strongly committed to protecting your privacy and providing a safe & high-quality online experience for all of our visitors. We understand that you care about how the information you provide to us is used and shared. We have developed a Privacy Policy to inform you of our policies regarding the collection, use, and disclosure of information we receive from users of our website. The Cheap Investor operates the Website.

Our Privacy Policy, along with our Term & Conditions, governs your use of this site. By using https://TheCheapInvestor/, or by accepting the Terms of Use (via opt-in, checkbox, pop-up, or clicking an email link confirming the same), you agree to be bound by our Terms & Conditions and our Privacy Policy. If you have provided personal, billing, or other voluntarily provided information, you may access, review, and make changes to it via instructions found on the Website or by emailing us at support@thecheapinvestor.com. To manage your receipt of marketing and non-transactional communications, you may unsubscribe by clicking the "unsubscribe" link located on the bottom of any marketing email. Emails related to the purchase or delivery of orders are provided automatically – Customers are not able to opt out of transactional emails. We will try to accommodate any requests related to the management of Personal Information in a timely manner. However, it is not always possible to completely remove or modify information in our databases (for example, if we have a legal obligation to keep it for certain timeframes, for example). If you have any questions, simply reply to this email or visit our website to view our official policies.

Update your email preferences or unsubscribe here

203 N La Salle Suite 2100
Chicago , Illinois 60601, United States

beehiiv logoPowered by beehiiv
Terms of Service

[Exclusive] Is Tesla a Half Off Coupon for SpaceX?

TSLA just got punished for a delivery miss. But what if the real trade is SpaceX at a massive discount?  ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌

IMPORTANT NOTICE AND DISCLAIMER
Investing Media Solutions, LLC ("IMS"), the owner of this website (the "Website"), cannot guarantee the accuracy or completeness of the information contained in any article, email, newsletter, or other publication posted on or viewed in connection with this website (the "Publications"). The author or authors of those Publications are solely responsible for their contents. IMS has not done any research or due diligence into the markets, industries, or companies which may appear or be mentioned in the Publications. IMS will NOT be liable for any loss or damage caused by a reader's reliance on information posted on the Website or contained in the Publications.

FOR EDUCATIONAL AND INFORMATIONAL PURPOSES ONLY; NOT INVESTMENT ADVICE.
This Website and the Publications are for educational and informational purposes only. This Website and the Publications do not purport to be a complete analysis of any company's financial position. This Website, the Publications or any statements made in the Publications are not, and should not be construed to be, personalized investment advice directed to or appropriate for any particular individual. This Website or the statements made in the Publications should NOT be relied upon for purposes of transacting in any securities posted on the Website or mentioned in the Publications, nor should they be construed as a personalized recommendation to you to buy, sell, or hold any position in any security posted on this Website or mentioned in any Publications.

SUBSTANTIAL RISK IN INVESTMENT.
Any individual who chooses to invest in any securities including those mentioned in the Publications should do so with caution. Investing or transacting in securities involves substantial risk; you may lose some, all, or possibly more than your original investment. Readers bear responsibility for their own investment research and decisions and should review all investment decisions with a licensed or registered investment professional.

NOT AN INVESTMENT ADVISOR OR REGISTERED BROKER
Neither IMS nor any of its respective owners or employees are registered or licensed as a securities broker-dealer, broker, an investment advisor, or an investment advisor representative with the U.S. Securities and Exchange Commission (SEC), any state securities regulatory authority, or any self-regulatory organization.

To more fully understand our Website, please review our full disclaimer located at: https://thecheapinvestor.com/disclaimer/

At The Cheap Investor, it's our mission to create and provide a community that helps you invest and understand stocks. When TheCheapInvestor was established, we wanted to make the community an inclusive place where investors can come to get ahead! Not just help them with daily stock picks. The Cheap Investor are provided to you for information only and should not be considered as a stock or investment advisor. The Cheap Investor may make available certain information related to trading strategies and stock prices for educational and information purposes only; any information made available should not be construed as an endorsement, recommendation, or sponsorship of any company or security. By visiting this site or using the training materials, you acknowledge and agree that any reliance upon the content or data available through The Cheap Investor is at your own sole risk. You are strongly advised to use your own judgment, research, and consult a professional advisor.

Over the years, and with thousands of followers that use our stock picks daily, we promise to always aim to get better at what we do every single day! In addition, our primary focus is on our communication with you. It's really important to us that every time you come to us, you end up leaving with the help you came for to take your investment portfolio to new levels.

We particularly appreciate when our following provides feedback via testimonials, reviews, and comments left on our site or social media accounts. Because with that feedback, we can use it to make your next visit to our site even better than the last!

Since we put so much effort into the relationship with you, we hope that any investment in us is exactly the way you hoped it would be. Because by choosing to go with https://TheCheapInvestor.com/, it's our promise that we provide a community you will come back to over and over again.

Now, as much as we care about making investors more successful, we also care about your privacy. TheCheapInvestor is owned and operated by TheCheapInvestor website.

We're committed to the right to your privacy and strive to provide a safe and secure user experience. Our Privacy Policy explains how we collect, store and use personal information, provided by you on our website.

What Information Do We Collect?

When you visit our Web site you may provide us with two types of information: personal information you knowingly choose to disclose that is collected on an individual basis and Web site use information collected on an aggregate basis as you and others browse our Web site.

For example, you may need to provide the following information: • Name • Website URL information • Email address • Home and business phone number

In addition to providing the foregoing information, if you choose to correspond further with us through email, we may retain the content of your email messages together with your email address and our responses. We provide the same protections for these electronic communications that we employ in the maintenance of information received by mail and telephone. It also explains important information that ensures we won't abuse the information that you provide to us in good faith. By accessing and using our website, you can trust that what you want to be kept private, will be kept private. If at any time, you would like to read our Privacy Policy and get a better understanding of your rights and liabilities under the law.

Feel free to visit our site, find the privacy policy in the footer and read it. If there is something you are concerned about or wish to get more clarity on, please let us know by contacting us at support@thecheapinvestor.com. The Privacy Policy also informs you of how to notify us to stop using your personal information. If you wish to view our official policies, please visit our website https://TheCheapInvestor.com/

At The Cheap Investor, we are strongly committed to protecting your privacy and providing a safe & high-quality online experience for all of our visitors. We understand that you care about how the information you provide to us is used and shared. We have developed a Privacy Policy to inform you of our policies regarding the collection, use, and disclosure of information we receive from users of our website. The Cheap Investor operates the Website.

Our Privacy Policy, along with our Term & Conditions, governs your use of this site. By using https://TheCheapInvestor/, or by accepting the Terms of Use (via opt-in, checkbox, pop-up, or clicking an email link confirming the same), you agree to be bound by our Terms & Conditions and our Privacy Policy. If you have provided personal, billing, or other voluntarily provided information, you may access, review, and make changes to it via instructions found on the Website or by emailing us at support@thecheapinvestor.com. To manage your receipt of marketing and non-transactional communications, you may unsubscribe by clicking the "unsubscribe" link located on the bottom of any marketing email. Emails related to the purchase or delivery of orders are provided automatically – Customers are not able to opt out of transactional emails. We will try to accommodate any requests related to the management of Personal Information in a timely manner. However, it is not always possible to completely remove or modify information in our databases (for example, if we have a legal obligation to keep it for certain timeframes, for example). If you have any questions, simply reply to this email or visit our website to view our official policies.

Update your email preferences or unsubscribe here

203 N La Salle Suite 2100
Chicago , Illinois 60601, United States

beehiiv logoPowered by beehiiv
Terms of Service